an introduction to synthetic clinical trial data€¦ · developing the core of the anzo platform...

53
An Introduction to Synthetic Clinical Trial Data October 4 th 2019 1

Upload: others

Post on 02-Aug-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

An Introduction toSynthetic Clinical Trial Data

October 4th 2019

1

Page 2: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Agenda

2

Page 3: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

[email protected]

For more information:

Page 4: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Appendices• Presenter biographies

4

Page 5: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Richard Hoptroff

5

Richard Hoptroff is a long term technology inventor, investor and entrepreneur. Awarded a Ph.D. in Physics by King’s College London for his work in optical computing and artificial intelligence. In 1992, he co-founded Right Information Systems, a neural net forecasting software company that was later sold to Cognos Inc (part of IBM).

He then worked as a postdoc at the Research Laboratory for Archaeology and the History of Art at Oxford University and in 2001, created Flexipanel Ltd, a company supplying Bluetooth modules to the electronics industry.

In 2010, he founded Hoptroff London, with the aim to develop smart, hyper-accurate watch movements and create a new watch brand. In 2013 Richard Hoptroff established a new commercial category when he brought to market the first commercial atomic timepiece and an atomic wristwatch.

Richard Hoptroff then leveraged his expertise in timing technology and software to develop a hyper-accurate synchronized timestamping solution for the financial services sector, based on a unique combination of grandmaster atomic clock engineering and proprietary software.

Page 6: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Lucy Mosquera

6

Lucy Mosquera has a background in biology and mathematics, having done her studies at Queen's University in Kingston and the University of British Columbia. In the past she has provided data management support to clinical trials and observational studies at Kingston General Hospital. She also worked on clinical trial data sharing methods based on homomorphic encryption and secret sharing protocols with various companies.At Replica Analytics, Lucy is responsible for integrating her subject area expertise in health data into innovative methods for synthetic data generation and the assessment of that data, as well as overseeing our analytics program.

Page 7: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Rebecca Li

7

Rebecca Li, PhD, is the Executive Director of Vivli and on faculty at the Center for Bioethics at the Harvard Medical School. Previous to her current role she was the Executive Director of the MRCT Center of Brigham and Women’s Hospital and Harvard for over 5 years and remains a Senior Advisor at the Center. The MRCT Center is a neutral convening organization that works to define actionable policy solutions for the clinical trial enterprise. She has over 20 years of experience spanning the entire drug development process with experience in Biotech, Pharma and CRO environments. She completed a Fellowship in 2013 in the Division of Medical Ethics at Harvard Medical School. Dr. Li also served as the VP of Clinical Research at the New England Research Institutes for 6 years. She was also previously employed at Wyeth Research as the Associate Director in Translational Clinical Research. She earned her PhD in Chemical and Biomolecular Engineering from Johns Hopkins University.

Page 8: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Ben SzekelyBen is Senior Vice President, Head of Field Operations at Cambridge Semantics Inc. As a Founding Engineer of Cambridge Semantics, Ben has impacted all sides of the business from developing the core of the Anzo Platform to leading early business development and customer engagements.

Ben currently leads a rapidly growing team of software engineers and data gurus to identify and deliver high value Anzo Smart Data solutions to Cambridge Semantics’ customers and partners across Pharma, Financial Services and Government.

Before joining the founding team at Cambridge Semantics, Ben worked as an Advisory Software Engineer at IBM with CSI founder and CTO Sean Martin on early research projects in Semantic Technology.

He has BA in Math and Computer Science from Cornell University and an SM in Computer Science from Harvard University.

8

Page 9: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

Introduction to Synthetic DataLucy Mosquera

October 4, 2019

1

Page 10: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

What is Synthetic Data ?• Data that is generated from real data, but is not real data.

It has the same statistical properties as real data.

• Models (statistical machine learning and deep learning)

are built from the real data and sample from these models

to create synthetic data.

• Because it is not real data, it will not have the same

privacy risks as real data. We can explicitly test that

assumption.

2

Page 11: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Deep Fakes

3

Page 12: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Types of Synthetic Data• Data synthesis can be performed on different types of

data:• Structured data

• Images

• Video

• Audio

• Text

• Our focus is on structured data

4

Page 13: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Basic Example - MethodThis is a simple example to illustrate how synthesis is performed

– to make the process concrete. The method used in the example is not something to apply in practice.

• State-wide hospital discharge dataset• Three variables of interest to illustrate the concepts:

• Age at time of visit (in years)• Days since last visit• Length of stay

• Removed all births from the dataset (n=189,047 discharges)

5

Page 14: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Basic Example - Method• Synthetic data is generated by:• Sampling from the fitted distributions• Inducing the non-parametric correlations among the values during

sampling• We use automated distribution fitting using the AIC criterion to determine

the best fit for each variable• We compute the empirical non-parametric correlation

The result is a synthetic dataset that has the same distributions as the original data and has the same bivariate correlations as

the original data

6

Page 15: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Marginal Distributions

7

Page 16: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Marginal Distributions

8

Page 17: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Marginal Distributions

9

Page 18: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Correlations

10

Page 19: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Similarity to Real CT Data

11

Page 20: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Why Synthetic Data ?• Getting access to good quality realistic data for AI and

machine learning projects is difficult (time consuming and

costly, and in some cases not possible) – data protection

regulations and cross-border data transfer concerns are a

major factor causing this

• This slows down the ability to build and test models, and to

evaluate models and analytics technologies

12

Synthetic data is a cost effective and scalable way to solve this problem

Page 21: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Generation Methods - A

13

Page 22: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Generation Methods - B

14

Page 23: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

General Workflow

15

Page 24: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

How Good Is the Data ?• Utility tests are performed on the data generated• They compare analysis results from the real vs

synthetic data (i.e., the absolute difference between the distributions or parameters for the real vs synthetic data)

• There are different ways to do this:• All univariate, bivariate, and multivariate models are compared (all

models test)• Replicate on synthetic data the published analyses from real data

16

Page 25: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

17

Page 26: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

18

Page 27: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Privacy Assurance• Replica Analytics has a unique privacy assurance

framework to quantitatively assess the risk of meaningful identity disclosure:1. The likelihood that an individual in the synthetic data can be matched with a

real person2. If such a match is possible, will the adversary learn something new from such

a match (because the data is fully synthetic, even if there is a match the information may be sufficiently different that nothing meaningful would be learned)

• Both tests must pass for a meaningful identity disclosure to have occurred

19

Page 28: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Synthesis CoE• A data synthesis Center of Excellence (CoE) is an

internal resource within the organization to:• Generate synthetic data for client projects and for internal analytics and

software testing efforts

• Consult on data synthesis with groups within the business

• Provide external facing experts to clients, regulators, and the media

about data synthesis methods and their application within the enterprise

• Promote best practices on the use of synthetic data within business

units and with clients (an education role)

20

Page 29: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Setting up a CoE• A Synthesis CoE can be set up by:

• Providing technology for data synthesis

• Training the CoE team on data synthesis methods

• Supports the development of SOPs and policies for the use

of synthetic data within the enterprise

• Advises on the implementation of governance mechanisms

supporting the use of synthetic data internally and

externally

21

Page 30: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Why Synthetic Data ?• The data utility is improving rapidly and models built

with synthetic data give similar results as the original

data

• Data synthesis can be largely automated and scaled

– there is little manual effort needed in the

generation process

• The number of use cases where this is a good

solution is increasing

22

Page 31: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

Case StudiesRebecca Li,

Vivli

Ben SzekelyCambridge Semantics

23

Page 32: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

Vivli ClinicalResearchDataSharing:Share.Discover.Innovate.

RebeccaLiOctober4th,2019

Page 33: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

Vivli isaGlobalDataPlatform– AgnostictoDisease,FunderorDataContributor

Page 34: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

VivliMembers

Page 35: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

HowVivliworks

Page 36: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

Vivli-MicrosoftDatathon ScientificObjective

• Background - Morethan60individualsformed11teamsandparticipatedinthefirstVivli MicrosoftDataChallenge.Participantswerefromuniversities,hospitals,pharmaceutical,biotechandsoftwarecompanies.

• Objective – Tofindinnovativesolutionsforhowtosafeguardparticipantprivacyandminimizeprivacylosswhilemaintainingthescientificanalyticvalueofthedataforrarediseasedatasetsthataremorehighlyidentifiable.

Page 37: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

We apply semantics and graph to a data fabric – so anyone can find, understand, blend, and use enterprise data.

At a Glance:

• Based in Boston• 100+ employees• Origins in IBM and Netezza • Anzo 4.0 GA 2017• Added enterprise-scale OLAP

graph database engine in 2015

Page 38: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

©2018CambridgeSemanticsInc.Allrightsreserved.

Page 39: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

NEWSROOMPress ReleaseGartner Identifies Top 10 Data and Analytics Technology Trends for 2019Augmented Analytics and Artificial Intelligence in the Spotlight

Trend No. 1: Augmented AnalyticsTrend No. 2: Augmented Data ManagementTrend No. 3: Continuous IntelligenceTrend No. 4: Explainable AI

Trend No. 5: GraphTrend No. 6: Data FabricTrend No. 7: NLP/ Conversational AnalyticsTrend No. 8: Commercial AI and MLTrend No. 9: BlockchainTrend No. 10: Persistent Memory Servers

….Graphprocessingtocontinuouslyacceleratedatapreparationandenablemore complexandadaptivedatascience.

…toefficientlymodel,exploreandquerydatawithcomplexinterrelationshipsacrossdatasilos

…..theneedtoaskcomplexquestionsacrosscomplexdata,whichisnotalwayspracticalorevenpossibleatscaleusingSQLqueries.

…..Datafabricenablesfrictionlessaccessandsharingofdatainadistributeddataenvironment.

……Itenablesasingleandconsistentdatamanagementframework,whichallowsseamlessdataaccessandprocessingbydesignacrossotherwisesiloedstorage.

Page 40: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

AnzoDifference:

GraphDataModels&Semantics

Simplifiesaccesstocomplexandblendeddatatoaddressunanticipatedquestions

Quicklyprofiles,connectsandharmonizesdatafrommultiplesources,includingunstructuredtextualsources

Presentstailoredviewsandexperiencestodifferentpersonaswithconceptualmodelsthatusebusinessterms

Flexiblyaccommodatesnewdatasourcesandusecasesonthefly,withminimalimpact

Scaleshorizontallytoaccommodateenterprisedatafabricscale

Page 41: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

Amoderndatadiscoveryandintegrationplatformforyourenterprisedatafabric.

Anzoletsbusinessusersfind,connect,andblendenterprisedataintoanalyticreadydatasets.

MapandExploreEnterpriseData

BuildBlendedAnalytic-Ready

Datasets

ApplyEnterprise-ReadyDataManagement

Page 42: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

©2019CambridgeSemanticsInc.Allrightsreserved.

AnzoProofofConceptwithReplicaAnalytics

OurPlanforthePoC• Blenddataintoacommonmodelatscale• Findinsightsfromdataacrossstudies,domains,andsubjects

Data• 2SyntheticStudyDatasets• 12CSVfiles

GraphApproachesApplied• Mapstudydatasetsandtheirmetadatatoacommongraphmodel• Usethegraphtoautomatethemappingstothemodel• Askquestionsonasinglegraphthatcontainscleaned,conformeddatafromacrossdatasets

Page 43: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

©2019CambridgeSemanticsInc.Allrightsreserved.

SummaryofPoCAchievementsTo-Date

Access● Answeredexploratoryquestionsacrossmultiplestudies● DemonstratedintegrationwithSpotfire

Blend● Appliedgraphmodeltoconnectentitiesviasubjectrelationships● Connectedstudiesviacommonentities(e.g.Disease)

OnboardandModel● MappedstudiestoSDTMv3.2standard● Conformed8domainsfrom12CSVfiles

Page 44: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

©2019CambridgeSemanticsInc.Allrightsreserved.

ConformeddataaccessibleinAnzo● 9Classes● 14DataLayers● 5Dashboards● 10+visualizations

SDTM3.2ModelforthePoC

Centralizedkeyconceptsandrelatedproperties● 2studies● 8domains● 75properties

Page 45: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

©2019CambridgeSemanticsInc.Allrightsreserved.

SearchAcrossStudiesinDashboards

● Searchandanalyzerelateddataacrossstudiesfromaunifieddashboard○ Adverseeventsbycomorbidities○ Treatmentsbydemographics○ Responsesbylabs

● Easilyincludeadditionalstudies

Page 46: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

©2019CambridgeSemanticsInc.Allrightsreserved.

DrillDowntoUnderstandRootCauses

● Identifyrootcauses● Drill-downtoexaminetrendsandoutliers

Page 47: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

©2019CambridgeSemanticsInc.Allrightsreserved.

AccessDatainAnzo

QueryusingODatastandardbasedonHTTP/REST

StandardwithsupportinglibrariesandintegrationswithmanyBIandanalyticstools

QuerythegraphthroughanHTTPendpointwithaSPARQLquery

SELECT ?mutation ?id WHERE {?mutation tcga:ssm_id ?id .

}

SPARQLisaquerylanguagethatisfamiliartothosewithSQLexperience

Highlyflexibleforextractingdatasetsfromthecompletegraph

JDBCisastandardprotocolforconnectingJavaApplicationstorelationaldatabases.

AnzoalsosupportsODBC.

Hi-ResAnalytics

Anzo’sexploratoryanalyticstoolforqueryingandvisualizingdata

Greatforexploration,discoveringrelationshipsindata,anddrilling-downintohierarchicaldata.

Easytocreateself-servicedataproductsforexportswiththeothertoolsmentionedhere.

Page 48: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

©2019CambridgeSemanticsInc.Allrightsreserved.

AccessDatainSpotfire

AlldataisaccessibleinSpotfireviaanODataendpoint

Page 49: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

©2017 Cambridge Semantics Inc. All rights reserved.

End-to-endDataProvenance

DataSources DataSourceMetadata

Mappings Models Datasets Graphmarts Dashboards

Page 50: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

QUESTIONScc:anuntrainedeye- https://www.flickr.com/photos/26312642@N00

Page 51: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

You will receive• The materials from this webinar• Over the next couple of weeks we will send you the

reports that were mentioned in this webinar as well:• Accelerating AI Using Synthetic Data report• Technical report on data utility evaluation• Notice about the book on synthetic data generation when it comes out in

2020

• An invitation to the synthetic data privacy assurance webinar later this year

2

Page 52: An Introduction to Synthetic Clinical Trial Data€¦ · developing the core of the Anzo Platform to leading early business development and customer engagements. Ben currently leads

(c) Copyright 2019 Replica Analytics Ltd. All Rights Reserved.

Next Steps• If you want to learn more about synthetic data please

contact us: [email protected]

• You will be asked to opt-in to receive more information from us (technical reports and whitepapers, future webinars on AI and synthetic data, live events that we organize, and newsletters) that may be of interest to you. It is important that you opt-in to continue to receive these communications.

3